PharmAnalysis Group Mergers & Acquisitions

PharmAnalysis Group M&A Summary

PharmAnalysis Group has acquired 1 company.

PharmAnalysis Group has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

PharmAnalysis Group, Inc.

1800 North Beauregard Street Suite 150,
Alexandria, Virginia 22311
United States,
(703) 998-9100
www.pharmanalysisgroup.com

All (1) Buy (1) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2004-08-09 UBC · Life Science
Blue Bell, Pennsylvania · www.ubc.com

UBC engages in the biopharmaceutical market which provides integrated clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. UBC was founded in 2003 and is based in Blue Bell, Pennsylvania.

- Add-on Acquisition

PharmAnalysis Group, Inc.
Advisor: Edgemont Capital Partners

- -

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.